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1 Improved radiation expression profiling in blood by sequential application of sensitive and 
2 specific gene signatures
3 Abstract (word count = 365)
4 Purpose. Combinations of expressed genes can discriminate radiation-exposed from normal 
5 control blood samples by machine learning based signatures (with 8 to 20% misclassification 
6 rates). These signatures can quantify therapeutically-relevant as well as accidental radiation 
7 exposures. The prodromal symptoms of Acute Radiation Syndrome (ARS) overlap those present 
8 in Influenza and Dengue Fever infections. Surprisingly, these human radiation signatures 
9 misclassified gene expression profiles of virally infected samples as false positive exposures. The 
10 present study investigates these and other confounders, and then mitigates their impact on 
11 signature accuracy.
12 Methods. This study investigated recall by previous and novel radiation signatures independently 
13 derived from multiple Gene Expression Omnibus datasets on common and rare non-malignant 
14 blood disorders and blood-borne infections (thromboembolism, S. aureus bacteremia, malaria, 
15 sickle cell disease, polycythemia vera, and aplastic anemia). Normalized expression levels of 
16 signature genes are used as input to machine learning-based classifiers to predict radiation 
17 exposure in other hematological conditions. 
18 Results. Except for aplastic anemia, these blood-borne disorders modify the normal baseline 
19 expression values of genes present in radiation signatures, leading to false-positive 
20 misclassification of radiation exposures in 8 to 54% of individuals. Shared changes, predominantly 
21 in DNA damage response and apoptosis-related gene transcripts in radiation and confounding 
22 hematological conditions, compromise the utility of these signatures for radiation assessment. 
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1 These confounding conditions (sickle cell disease, thromboembolism, S. aureus bacteremia, 
2 malaria) induce neutrophil extracellular traps, initiated by chromatin decondensation, DNA 
3 damage response and fragmentation followed by programmed cell death. Riboviral infections (for 
4 example, Influenza or Dengue fever) have been proposed to bind and deplete host RNA binding 
5 proteins, inducing R-loops in chromatin. R-loops that collide with incoming replication forks can 
6 result in incompletely repaired DNA damage, inducing apoptosis and releasing mature virus. To 
7 mitigate the effects of confounders, we evaluated predicted radiation-positive samples with novel 
8 gene expression signatures derived from radiation-responsive transcripts encoding secreted blood 
9 plasma proteins whose expression levels are unperturbed by these conditions. 
10 Conclusions. This approach identifies and eliminates misclassified samples with underlying 
11 hematological or infectious conditions, leaving only samples with true radiation exposures. 
12 Diagnostic accuracy is significantly improved by selecting genes that maximize both sensitivity 
13 and specificity in the appropriate tissue using combinations of the best signatures for each of these 
14 classes of signatures.
15
16 Keywords: Biodosimetry, Gene expression, False positive reactions, DNA damage response 
17 (DDR), Radiation
18
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2 One of the most promising approaches to quantify absorbed ionizing radiation is based on levels 
3 of different gene expression responses in blood (Dressman et al. 2007; Paul and Amundson, 2008; 
4 Ding et al. 2013; Lu et al. 2014). Combinations of gene expression levels, termed signatures, can 
5 predict ionizing radiation exposure in humans and mice from publicly available microarray gene 
6 expression levels (Zhao et al. 2018a). Several groups (Boldt et al. 2012; Budworth et al. 2012; 
7 Knops et al. 2012; Ghandhi et al. 2017) have also used signatures to determine radiation exposures. 
8 Our approach uses supervised machine learning (ML) with genes previously implicated or 
9 established from genetic evidence and biochemical pathways that are altered in response to these 
10 exposures (Zhao et al. 2018a). Biochemically-inspired ML is a robust approach to derive 
11 diagnostic gene signatures for radiation and chemotherapy (Dorman et al. 2016; Mucaki et al. 
12 2016; Mucaki et al. 2019; Bagchee-Clark et al. 2020). Given the limited sample sizes of typical 
13 datasets, appropriate ML methods for deriving gene signatures have included Support Vector 
14 Machines, Random Forest classifiers, Decision Trees, Simulated Annealing, and Artificial Neural 
15 Networks (Rogan, 2019; Boldrini et al. 2019). 
16 Before performing ML, we ranked a set of curated radiation-response genes in radiation-
17 exposed samples by Minimum Redundancy Maximum Relevance (mRMR; Ding and Peng; 2005), 
18 which orders genes based on mutual information between their expression and whether the sample 
19 was irradiated (MR) and the degree to which their expression profile is dissimilar from previously 
20 selected genes (mR). A Support Vector Model (SVM) or signature is generated from the top ranked 
21 gene set by adding and removing genes that minimize either model misclassification or log-loss 
22 (Zhao et al. 2018a). ML alone is not sufficient to derive useful signatures, since underlying 
23 biochemical pathways and disease mechanisms also contribute to selecting relevant and non-
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1 redundant gene features (Bagchee-Clark et al. 2020). Signatures were evaluated either by a 
2 traditional validation approach or by stratified k-fold validation (which splits the same dataset into 
3 k groups reserved for testing and training). The traditional model-centric approach uses a 
4 normalized training set which is then used to predict outcome of normalized independent test data. 
5 While more susceptible to batch effects than k-fold validation, this approach can incorporate 
6 smaller datasets or heterogeneous data sources.
7 The present study is concerned with the selection of "normal" controls for training and 
8 testing signatures. Selection of appropriate controls has been a debated subject in other medical 
9 fields (Lipsitch et al. 2011). In individuals with clinically overlapping diagnoses, this has a critical 
10 but underappreciated impact on the accuracy of molecular diagnostic testing. Previous studies have 
11 revealed gene expression changes in blood from unirradiated individuals with underlying 
12 metabolic or confounders, including smokers (Paul and Amundson, 2011) and modulators of 
13 inflammation such as lipopolysaccharide of bacterial origin or curcumin (Cruz-Garcia et al. 2018). 
14 There is also evidence of interactions between hematological comorbidities and radiation 
15 exposure. Radiodermatitis has been associated with S. aureus infections (Hill et al. 2004). 
16 Radiation therapy has also been contraindicated in individuals with venous thromboembolism 
17 (Guy et al. 2017). 
18 While investigating the possibility of using radiation gene signatures to differentiate the 
19 prodromal phase of Acute Radiation Syndrome (ARS) from early-stage Influenza, riboviral 
20 infections induced expression changes similar to those seen in gamma-irradiated samples (Rogan 
21 et al. 2021). Radiation signatures misclassified some unirradiated blood samples from infected 
22 individuals as radiation-exposed (derived in Zhao et al. 2018a; designated M1-M4 in Rogan et al. 
23 2021). False positive radiation exposure predictions of unirradiated samples from individuals 
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1 diagnosed of Influenza has also been noted by others (Jacobs et al. 2020 [Supplementary data]). 
2 The M1-M4 signatures consisted predominantly of genes with roles in DNA damage response, 
3 programmed cell death, and inflammation. However, many of these genes were also similarly 
4 dysregulated in blood from Influenza and Dengue virus-infected samples. The expression of the 
5 DNA damage response gene DDB2, for example, increases with radiation, but was also induced 
6 in a significant number of viral infected samples which were then classified incorrectly as radiation 
7 exposed (Figure 5 of Rogan et al. 2021). DDB2 is present in many other radiation gene signatures 
8 or developed radiation-exposure assays (Paul and Amundson, 2008; Lu et al. 2014; Jacobs et al. 
9 2020).
10 While this process strictly validates signatures to estimate sensitivity to radiation, the same 
11 rigor has not been applied to determining specificity, which we suspected could be impacted by 
12 comorbidities in the general population. This study considers other hematological conditions that 
13 alter the normal expression of the same genes in blood that are often selected for assessment of 
14 radiation exposure and suggests an approach for addressing this issue.
15 We evaluated gene expression data from other individuals with blood-borne conditions 
16 (infections, inherited and idiopathic hematological disorders) to determine whether previous and 
17 novel gene signatures could discriminate radiation exposure from these phenotypes. We 
18 investigate whether these effects are reproducible using newly derived signatures from 
19 independent datasets derived from irradiated blood samples (Figure 1).
20 [Figure 1 Near Here]
21 Methods
22 Datasets evaluated
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1 Expression data from the Gene Expression Omnibus [GEO; https://www.ncbi.nlm.nih.gov/geo/] 
2 and Array Express [https://www.ebi.ac.uk/arrayexpress/] databases were required to contain the 
3 same genes in each signature in both training and independent validation radiation datasets (Zhao 
4 et al. 2018a). These datasets were: GSE1725 [Designated: RadLymphCL-1], GSE6874 [GPL4782; 
5 Designated: RadTBI-2], GSE10640 [GPL6522; Designated: RadTBI-3] and GSE701 [Designated: 
6 RadLymphCL-4] (Table 1). Several well known radiation genes which have appeared in other 
7 radiation gene signatures (Paul and Amundson, 2008; Oh et al. 2014; Port et al. 2017; Tichy et al. 
8 2018; Jacobs et al. 2020) were previously not considered and were not present in any of our former 
9 ML models. Genes were excluded either because they were: 1) absent from one or more datasets 
10 (e.g. FDXR, RPS27L, AEN were missing from RadTBI-3); 2) mislabeled in the dataset with a 
11 legacy name leading to a mismatch between datasets (e.g. PARP1 appears as ADPRT in RadTBI-
12 2); 3) secondary RNAs, such as micro- or long non-coding-RNA derived from the same gene (e.g. 
13 BBC3 probes also detected multiple microRNAs in RadLymphCL-1; POU2AF1 probes in 
14 RadLymphCL-4 indicated as LOC101928620’); or 4) missing from the set of curated radiation 
15 response genes (e.g. PHPT1, VWCE, WNT3).
16 To address the possibility that inclusion of genes missing from signatures based on 
17 RadLymphCL-1, RadTBI-2 or RadTBI-3 might improve radiation response prediction, we 
18 developed novel signatures from more recent radiation datasets, including GEO: GSE26835, 
19 GSE85570, GSE102971 and ArrayExpress: E-TABM-90 (Designated RadLymphCL-5, 
20 RadBloodpost-6, RadBlood-7, and RadBloodpost-8, respectively; Table 1). Previous radiation 
21 gene signatures (Zhao et al. 2018a) were derived from GSE6874[GPL4782] and 
22 GSE10640[GPL6522] (RadTBI-2 and RadTBI-3, respectively; bracketed accession numbers refer 
23 to the subset of samples belonging to a corresponding GEO SuperSeries). Exposure levels were at 
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1 a minimum of 2Gy (including total body irradiation [TBI]) and were carried out between 4-24 
2 hours post-irradiation for all radiation-derived signatures.
3 To investigate whether other disorders could also confound radiation signatures, we 
4 assessed performance of radiation signatures utilized in this study with available gene expression 
5 datasets for other blood-borne diseases. These datasets include GEO: GSE117613 (cerebral 
6 malaria and severe malarial anemia; Designated: BBD-Malaria [BBD – Blood Borne Disease]), 
7 GSE35007 (sickle cell disease in children; Designated: BBD-Sickle), GSE47018 (polycythemia 
8 vera; Designated: BBD-Polycyt), GSE19151 (single and recurrent venous thromboembolism; 
9 Designated: BBD-Thromb), GSE30119 (Staphylococcus [S.] aureus infection; Designated: BBD-
10 Saureus), and GSE16334 (aplastic anemia; Designated: BBD-Aanemia) (Table 1). Gene 
11 expression was measured by microarray in each dataset (qRT-PCR validation data was not 
12 available). An idiopathic portal hypertension dataset (GSE69601) was excluded due to insufficient 
13 numbers of samples (N=6).
14 [Table 1 Here]
15 Data Preprocessing
16 Microarray data from each dataset were pre-processed as described in Zhao et al. (2018a). Briefly, 
17 missing gene expression values were imputed (gene feature was removed if values were missing 
18 from >5% samples) from nearest neighbours, the expression values of patient replicates were 
19 averaged, and gene expression of all genes were z-score normalized. Genes previously implicated 
20 in the radiation response (N=998) were analyzed, including 13 additional radiation genes described 
21 in other studies, including CD177, DAGLA, HIST1H2BD, MAMDC4, PHPT1, PLA2G16, PRF1, 
22 SLC4A11, STAT4, VWCE, WLS, WNT3, and ZNF541 (N=1,011 genes total).
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1 Derivation of Radiation Gene Signatures
2 mRMR ranking was determined for curated, expressed radiation-related genes in the presence or 
3 absence of radiation. mRMR first selects the gene with the highest mutual information (MI; Cover 
4 and Thomas, 2006; Zeng 2015) between its expression level and the radiation exposure status of 
5 each sample. MI ranges from 0 to 1 bit for a gene for a set comprised of radiated and unirradiated 
6 samples and measures the mutual dependence between the radiation exposure status and 
7 expression for each gene within the same dataset. With MI = 1 bit, expression levels and radiation 
8 exposure are perfectly correlated. Expression levels of a gene that distinguish some but not all 
9 irradiated and unirradiated samples produce MI values between 0 and 1. A low MI value ~0 bits 
10 indicates that expression levels are weakly or uncorrelated with the radiation phenotype. mRMR 
11 feature selection then minimizes redundant expression patterns among the genes chosen by 
12 prioritizing gene candidates with the highest difference between its MI and the average MI of all 
13 previously selected genes with the candidate gene as a probability vector (Ding and Peng, 2005; 
14 Mucaki et al. 2016). Minimizing redundancy results in some subsequent selected gene(s) with 
15 orthologous expression patterns relative to the preceding gene(s). These may exhibit significantly 
16 lower MI, typical of a weak radiation response. Nevertheless, higher ranked gene features exhibit 
17 larger MI values in general. Gene rankings by mRMR and the computed MI for each radiation 
18 gene in each of the datasets evaluated are provided in Suppl. Table S1.
19 SVM-based gene signatures were derived by greedy feature selection, including forward 
20 sequential feature selection (FSFS), backward sequential feature selection (BSFS) and complete 
21 sequential feature selection (CSFS; Zhao et al. 2018a). Our software for biochemically-inspired 
22 ML is available in a Zenodo archive (Zhao et al. 2018b). Both FSFS and BSFS models were 
23 derived from the top 50 ranked mRMR genes, in addition to other published radiation responsive 
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1 genes: AEN, BAX, BCL2, DDB2, FDXR, PCNA, POU2AF1, and WNT3. SVMs were derived with 
2 a Gaussian radial basis function kernel by iterating over box-constraint (C) and kernel-scale (σ) 
3 parameters and gene features, minimizing to either misclassification or log loss by cross-validation 
4 (Zhao et al. 2018a; Bagchee-Clark et al. 2020). Gene signatures were then assessed with a 
5 validation dataset and re-evaluated (by misclassification rates, log loss, Matthews correlation 
6 coefficient, or goodness of fit). This study primarily reports misclassification rates to simplify 
7 comparisons of results between radiation-exposed and disease confounder datasets. Those with 
8 high misclassification rates in validated radiation datasets (>50%) have been excluded. Variation 
9 in radiation signature composition among different source datasets can be attributed to distinct 
10 microarray platforms, other batch effects, and inter-individual variation in gene expression which 
11 cannot be fully mitigated by normalization. These contribute to MI variability, which both alters 
12 mRMR rank and features selected during signature derivation.
13 The quality of each dataset was assessed based on the dynamic range in responses by 
14 signature genes to radiation. This was based on the premise that these responses among different 
15 confounding datasets might alter expression of some of the same radiation-responsive genes. MI 
16 between gene expression and radiation dose is indicated in Suppl. Table S1. Datasets 
17 RadBloodpost-6 and RadBlood-7 both exhibit high MI with radiation exposure (maximum MI > 
18 0.7 bits for both datasets; 77 and 115 genes with > 0.2 bits MI, respectively). By contrast, datasets 
19 RadLymphCL-5 and RadBloodpost-8 both exhibited low MI for top ranked genes with radiation 
20 exposure. Of the top 50 ranked genes in dataset RadBloodpost-8, 13 genes had MI values <10% 
21 of the MI of the top ranked gene [0.3 bits], and 856 of 860 genes in the complete dataset had MI 
22 < 0.2 bits. The maximum MI for RadLymphCL-5 was 0.25 bits; 40 of 50 top ranked genes 
23 exhibited <10% MI of this value, and the radiation response genes DDB2, PCNA, FDXR, AEN, 
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1 and BAX, had unexpectedly low rankings (>100; 2h and 6h post-exposure) and MI < 0.15 bits. The 
2 low MIs across all eligible genes indicates that the response to radiation was nearly random in both 
3 datasets. These datasets failed to satisfy minimum quality criteria and were excluded from further 
4 analyses. Radiation toxicity in dataset RadBloodpost-8 and cell line immortalization in 
5 RadLymphCL-5 appears to compromise their radiation response.
6 Radiation gene signatures derived from expressed genes encoding secreted factors originating 
7 from blood cells
8 Only genes that encoded proteins present in blood plasma were used to derive an alternate set of 
9 gene expression signatures. The initial set of plasma proteins from the Human Protein Atlas 
10 “Human Secretome” [http://www.proteinatlas.org/humanproteome/secretome] and the Plasma 
11 Protein Database [http://www.plasmaproteomedatabase.org] were cross-referenced to create a list 
12 of 1377 shared proteins. The Genotype-Tissue Expression (GTEx) Portal 
13 (https://gtexportal.org/home/) was used to determine which genes encoding these secreted proteins 
14 are expressed in either leukocytes or transformed lymphoblasts at detectable levels (where 
15 Transcripts Per Million (TPM) > 1; N=682). Expressed genes present in radiation datasets 
16 RadTBI-2 (N=428) and RadTBI-3 (N=325) were used to derive ML models of genes encoding for 
17 human plasma proteins using CSFS, BSFS, and FSFS. 
18 Evaluating specificity of radiation gene signatures with expression of genes in confounding 
19 hematological conditions
20 Radiation gene signatures derived in this study (M5-M20) and in Zhao et al. (2018a) (M1-M7, 
21 KM3-KM7) were used to evaluate datasets consisting of independent expression measurements of 
22 the same gene features in samples derived from hematological disorders and controls (Table 1). 
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1 Traditional ML validation was performed using available software 
2 (‘regularValidation_multiclassSVM.m’; Zhao et al. 2018b). This software performs quantile 
3 normalization to the features of the training and test set together (making the distributions of the 
4 two datasets statistically identical) before fitting a model to the training data which is then used to 
5 predict exposure based on the normalized expression of the test set. We evaluated how often these 
6 unirradiated individuals were misclassified as radiation-exposed by these models. Significant 
7 differences between false positive (FP) blood-borne cases and controls for the same signature were 
8 determined with the Mantel-Haenszel chi square and Mid-P exact tests, using a threshold of p = 
9 0.05. Assessing unirradiated expression datasets featuring patients with hematological or 
10 infectious conditions using radiation signatures will not yield any true positive (TP) or false 
11 negative (FN) cases. This is because our experimental design did not merge radiation and 
12 confounder datasets by joint normalization of expression values. Normalization often does not 
13 adequately account for variations due to batch effects or between different microarray platforms. 
14 Furthermore, we cannot exclude that irradiated samples from healthy individuals may mask 
15 underlying blood-based phenotypes that were not documented in published studies. For these 
16 reasons, radiation and hematological disorder datasets were evaluated separately with the same 
17 signatures for FP and TN levels only, rather than by positive or negative predictive values. We 
18 determined the impact of genes in each signature on misclassification by iteratively removing 
19 individual gene features, rederiving signatures with these genes, and redetermining 
20 misclassification rates using expression data from hematological or infectious diseases (Zhao et 
21 al. 2018a; Mucaki et al. 2019). Expression levels of radiation responsive genes in confounder 
22 datasets of correctly vs. misclassified samples were contrasted using violin plots. These display 
23 weighted distributions of the normalized gene expression from each confounder datasets which 
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1 were either properly (true negative [TN]) and improperly (FP) classified as irradiated by the 
2 radiation gene signatures (created in R [i386 v4.0.3] with ggplot2). Counts of confounder sub-
3 phenotypes were stratified using Sankey diagrams (SankeyMATIC; 
4 http://sankeymatic.com/build/) which display the distribution of misclassified samples by 
5 phenotype. This analysis delineates FP and TN predictions (at the individual level) of groups of 
6 diseased patients and controls from these datasets according to predictions of the designated, 
7 specific radiation gene signature. 
8 Results
9 Initial Evaluation of Candidate Genes in Radiation Gene Expression Datasets for Machine 
10 Learning
11 We derived new gene expression signatures by leave-one-out and k-fold cross-validation from 
12 microarray data based on more recent comprehensive gene datasets (RadBloodpost-6 and 
13 RadBlood-7) besides those we previously reported (Zhao et al. 2018a). Only some of the 1,011 
14 curated genes were present on these microarray platforms, including 864 genes in RadBloodpost-
15 6 and 971 genes of RadBlood-7. After normalization, gene rankings by mRMR between datasets 
16 RadBloodpost-6 and RadBlood-7 were similar (Suppl. Table S1). In RadBloodpost-6, FDXR were 
17 ranked first, while AEN was top ranked in RadBlood-7 (FDXR was ranked 38th). DDB2 was top 
18 ranked in datasets RadTBI-2 and RadTBI-3 (Zhao et al. 2018a), datasets which lacked expression 
19 for FDXR and AEN, respectively. Radiation-response genes among the top 50 ranked genes present 
20 in all 4 datasets included BAX, CCNG1, CDKN1A, DDB2, GADD45A, PPM1D and TRIM22. 
21 ERCC1 was selected by mRMR to be the second-ranked gene in dataset RadBlood-7, even 
22 though its MI was 31-fold lower than the top ranked gene, AEN (Suppl. Table S1). MI of the 
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1 second-ranked genes in dataset RadTBI-2 (RAD17) was 7-fold lower than the first (DDB2), while 
2 dataset RadTBI-3 (CD8A) showed a 4-fold difference. Six of the top 50 genes in RadBlood-7 
3 exhibited <10% of the MI of AEN (3 genes for RadTBI-2; none of the top 50 in RadTBI-3 and 
4 RadBloodpost-6 were <10% of the top ranked gene). Selection of low MI genes by ML feature 
5 selection likely reduces accuracy of gene signatures during validation steps. In the future, signature 
6 derivation will set a minimum MI threshold for ranking genes by mRMR.  
7 The overall levels of MI for top ranked genes in datasets RadBloodpost-6 (0.72 bits for 
8 AEN) and RadBlood-7 (0.82 bits for FDXR) were comparable (Suppl. Table S1). In RadBlood-7, 
9 the genes with the highest MI were AEN, DDB2, FDXR, PCNA and TNFRSF10B (closely 
10 followed by BAX). While each were found in the top 50 ranked genes, some rankings were 
11 decreased to minimize redundant information (FDXR and AEN are ranked #38 and #41 in the 
12 RadBlood-7 dataset, respectively). MI for the top ranked genes in datasets RadTBI-2 and RadTBI-
13 3 were lower by comparison (0.31 and 0.47 bits for DDB2, respectively); the depressed maximum 
14 MI values in these datasets may, in part, be related to reduced numbers of eligible genes on these 
15 microarray platforms.
16 Radiation Gene Signature Performance in Blood-Borne Diseases 
17 The specificity of previously-derived radiation signatures selected after k-fold validation (KM1-
18 KM7) and traditional validation (M1-M4; Zhao et al. 2018a) was assessed with normalized 
19 expression data of patients with unrelated hematological conditions, rather than evaluating 
20 unirradiated healthy controls. Signatures M1 and M2 (derived from dataset RadTBI-3; Table 2) 
21 and M3 and M4 (derived from RadTBI-2; Table 2) were assessed with multiple expression datasets 
22 from Influenza A (BBD-Flu##) and Dengue fever (BBD-Deng##) blood infections (Rogan et al. 
23 2021; Table 1). FPs for radiation exposure were defined as instances where the misclassification 
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1 rates of individuals with the disease diagnosis exceeded normal controls. A clear bias towards FP 
2 predictions of infected samples relative to controls was evident with all of these radiation gene 
3 signatures (Rogan et al. 2020; extended data – Section 1 Table 7). Dissection of the ML features 
4 responsible implicated 10 genes contributing to misclassification, including BCL2, DDB2 and 
5 PCNA. These other conditions also confound predictions by radiation signatures derived by k-fold 
6 validation (KM1-KM7; Table 2). 
7 [Table 2 Here]
8 High levels of FP misclassification of viral infections were also evident with these 
9 signatures (Supp. Table S2A). KM6 and KM7 (derived from dataset RadTBI-2) misclassify all 
10 Influenza and most Dengue fever (BBD-Deng61, BBD-Deng08 and BBD-Deng78) datasets of 
11 patients at higher rates than uninfected controls. KM3-KM5 exhibited low FP rates in Influenza 
12 relative to other models, but Dengue virus datasets BBD-Deng62, BBD-Deng08 and BBD-Deng78 
13 exhibited higher FP rates in infected samples relative to uninfected controls (Suppl. Table S2A). 
14 Interestingly, KM5 is the only gene signature in which DDB2 is not present, and this gene 
15 contributes to high FP rates (Rogan et al. 2021). KM1 and KM2, which were derived from a third 
16 radiation dataset (RadLymphCL-1), often misclassified virus infected samples relative to controls 
17 (KM1 only: BBD-Deng61; KM2 only: BBD-Flu50, BBD-Flu31, BBD-Deng62 and BBD-Flu28; 
18 both KM1 and KM2: BBD-Deng08, BBD-Deng78, and BBD-Flu21). However, in some datasets, 
19 these models also demonstrated high FP rates in controls. 
20 Expression levels in patients with latent Influenza A and Dengue fever stabilize at levels 
21 similar to uninfected controls after either convalescence or at the end stage infection. For example, 
22 M4 exhibited a 54% FP rate in Dengue-infected individuals 2-9 days after onset of symptoms 
23 (BBD-Deng08), but samples were correctly classified as unirradiated > 4 weeks after initial 
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1 diagnosis (Figure 2A). The Influenza gene expression dataset BBD-Flu85 longitudinally sampled 
2 infected patients after initial symptoms at <72 hours [T1], 3-7 days [T2], and 2-5 weeks [T3]. FPs 
3 were significantly decreased at T3 for nearly all models tested (19 infected samples misclassified 
4 by M1 at T1 was reduced to 2 cases at T3; Figure 2B). These results clearly implicate these viral 
5 infections as the source of the transcriptional changes that affect parallel effects of radiation on 
6 these signature genes.
7 [Figure 2 Here]
8 Specificity of radiation signatures using datasets of other hematological conditions
9 We investigated whether radiation gene signature accuracy was compromised by the presence of 
10 other blood borne infections and non-infectious, non-malignant hematological pathologies with 
11 publicly available expression data on patients with adequate sample sets (>10 individuals with 
12 corresponding control samples except for aplastic anemia). These included thromboembolism, S. 
13 aureus bacteremia, malaria, sickle cell disease, polycythemia vera, and aplastic anemia. We then 
14 determined recall levels for signatures M1-M4 and KM3-KM7 evaluated with these datasets, with 
15 the expectation that these models would predict all potential confounders as unirradiated (Suppl. 
16 Table S2B).
17 Each radiation gene signature was confounded by some, but not all, blood-borne disorders 
18 and infections. S. aureus infected samples were frequently misclassified as FPs by all signatures, 
19 except KM7 (Figure 3). High FP rates were observed for: M1 and KM5 – sickle cell and S. aureus; 
20 M2 – S. aureus; M3 and M4 – malaria, sickle cell, thromboembolism, polycythemia vera and S. 
21 aureus; KM3 and KM4 – malaria, sickle cell and S. aureus; KM6 – thromboembolism, 
22 polycythemia vera, S. aureus; KM7 – malaria, thromboembolism and polycythemia vera. We 
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1 compared differences between FPs in patients and controls for each dataset using the Mantel-
2 Haenszel chi square and mid-P exact statistical tests (Figure 3 and Suppl. Table S2B). Predictions 
3 of model M4 significantly confounded misclassification of radiation exposure for all conditions 
4 tested (polycythemia vera was only significant with the mid-P exact test), while the FP rate of 
5 KM6 was significantly higher in patients with either thrombosis or S. aureus infection (p-values 
6 indicated in Suppl. Table S2B). The malaria dataset stratified patients with either cerebral malaria 
7 or severe malarial anemia (Nallandhighal et al. 2019). The severe malarial anemia subset contains 
8 the majority of the FPs (Figure 2C). The thromboembolism dataset (Lewis et al. 2011), which 
9 categorized patient diagnoses as either single or recurrent thromboembolism, exhibited similar FP 
10 rates for both subsets (Figure 2D). Predictions by M3, M4, KM6 and KM7 were confounded by 
11 transcriptional changes resulting from different blood-borne conditions, while M2 and KM5 are 
12 the least influenced by these conditions. Aplastic anemia did not increase FP rates compared to 
13 controls for any of the signatures, consistent with our previous findings (Rogan et al. 2021).
14 [Figure 3 Here]
15 Predictions of radiation exposure by signatures M4, KM6 and KM7 were confounded by 
16 multiple viral, blood-borne infections and non-infectious blood disorders (Suppl. Table S2A and 
17 S2B). The genes responsible for the high sensitivity of these signatures were evident by 
18 comparative expression levels correctly (TN) vs incorrectly (FP) classified samples. The 
19 normalized gene expression distributions of TN and FP samples in malaria, S. aureus, sickle cell 
20 disease, thromboembolism, Influenza A and Dengue fever were visualized as violin plots (Figure 
21 4 and Mucaki et al. 2021). The shared distributions in gene expression in FP confounders and 
22 radiation-exposed individuals can be observed without the need for advanced statistical 
23 measurements, however differences between TN and FP expression levels for the same gene were 
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1 frequently also statistically significant. For example, expression of BCL2 in sickle cell disease, 
2 and S. aureus and malaria infected samples was significantly lower in FP samples relative to TNs 
3 with M4 (p<0.05 with Student’s T-test, assuming two-tailed distribution and equal variance; 
4 Figure 4A [left]), similar to the effect of radiation exposure on expression of this gene (Figure 4A 
5 [right]). These same FP individuals have significantly higher DDB2 expression in both S. aureus 
6 and sickle cell disease (Figure 4B). Increased DDB2 expression was also observed for FPs using 
7 KM6 and KM7. For both genes, differences in expression in TN and FP samples were congruent 
8 with the changes observed in the radiation exposure datasets. Genes that may also contribute to 
9 misclassification include GADD45A in M4 (higher expression in diseased individuals vs. controls 
10 and induced by radiation exposure), and PRKCH and PRKDC, respectively, in KM6 and KM7 
11 (decreased expression in FPs and in response to radiation). BAX, which is induced by radiation, is 
12 similarly expressed in FP and TN samples, and probably does not contribute to misclassification 
13 by M4.
14 [Figure 4 Here]
15 To determine the extent to which each gene contributes to the FP rates in each signature, 
16 gene features were removed individually, the radiation signature was rederived by biochemically-
17 inspired ML, and misclassification rates were reassessed for each confounding condition (Suppl. 
18 Tables S3A [M1-M4] and S3B [KM3-KM7]). Removing any gene from gene signatures M1, M3, 
19 M4, KM3, KM5 and KM7 did not significantly alter the observed misclassification rates. 
20 Elimination of PRKDC (DNA double stranded break repair and recombination) and IL2RB (innate 
21 immunity/inflammation) reduced FP rates in thromboembolism patients by 10% and 5% for M4, 
22 respectively (Figure 5A), which still exceeded the FP rates of controls. Removal of these genes 
23 did not improve the FP rate of M4 in S. aureus-infected samples (Figure 5B). Thus, no single gene 
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1 feature dominated the predictions by these signatures and could account for the misclassified 
2 samples. Removal of DDB2, GTF3A or HSPD1 from KM4 significantly decreased its FP rate to 
3 the malaria dataset (18% to 0-3%; Suppl. Table S3B). Similarly, removal of DDB2 from M2 and 
4 KM6 led to the complete elimination of FPs in both patients and controls. However, the removal 
5 of DDB2 from these models was previously shown to severely reduce the true positive (TP) rate 
6 in irradiated samples (Zhao et al. 2018a); these genes cannot be eliminated without affecting the 
7 sensitivity of these signatures to accurately identify radiation exposed samples. 
8 [Figure 5 Here]
9 The contributions of individual signature genes can be assessed by evaluating their impact 
10 on overall model predictions for different patients. Expression changes were incrementally 
11 introduced to computationally determine the expression level required to change the outcome of 
12 the ML model (i.e. the inflection point of the prediction that distinguishes exposed from 
13 unirradiated samples). The threshold is visualized in the context of the expression value in the 
14 individual superimposed over a histogram of the distribution of expression for all confounders in 
15 the dataset. Individual expression values close to this threshold can indicate lower confidence in 
16 either the radiation exposure prediction or of misclassification by the model. Expression levels and 
17 thresholds of DDB2, IL2RB, PCNA and PRKDC for 3 individuals with thromboembolism (BBD-
18 Thromb) predicted as irradiated by M4 (GSM474819, GSM474822, and GSM474828) are 
19 indicated in Suppl. Figure S1. Reduction of DDB2 expression corrected misclassification for all 
20 patients, as did decreasing PCNA expression in GSM474822 and GSM474828. Increasing IL2RB 
21 and PRKDC expression of these two patients also corrected their misclassification. These results 
22 correspond to the effects of radiation on the expression of these genes in the RadTBI-2 and 
23 RadTBI-3 datasets, e.g. induction of DDB2 and PCNA, repression of IL2RB and PRKDC (Mucaki 
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1 et al. 2021). The expression changes required for DDB2, PCNA and PRKDC in these patients were 
2 nominal relative to the dynamic range of the entire dataset but were sufficient to alter predictions 
3 of the signatures. Conversely, changes in expression of PCNA, IL2RB or PRKDC were unable to 
4 modify the prediction of M4 in GSM474819. Only a large decrease in DDB2 expression to levels 
5 below those of nearly all other thromboembolism patients was able to switch the classification of 
6 this individual. This reinforces previous observations about the strong impact of DDB2 expression 
7 levels on prediction accuracy (Zhao et al. 2018a). Nevertheless, the combined expression of most 
8 of the genes which constitute the signature determine the classification result for each sample. 
9 Incorrect classifications where expression values are close to the model’s predictive inflection 
10 point are relevant when assessing misclassification accuracy. Generally, expression levels of most 
11 samples analyzed deviated significantly from these thresholds, leading to robust classifications by 
12 the M4 model. 
13 Misclassification of confounders with radiation gene signatures derived in this study
14 FSFS- and BSFS-based radiation gene signatures were derived from the top 50 ranked genes of 
15 datasets RadBloodpost-6 and RadBlood-7. RadBlood-7 contained sets of 20 samples, each 
16 irradiated at different absorbed energy levels (0 vs 2, 5, 6, and 7 Gy). Different ML models were 
17 derived either utilizing the full dataset or based on a combination of 2 and 5 Gy samples. The 
18 models derived from either subset of RadBlood-7 also exhibited very low misclassification (0-1 
19 samples) and log-loss (<0.01). Common genes selected from signatures derived from RadBlood-
20 7 included AEN, BAX, TNFRSF10B, RPS27L, ZMAT3 and BCL2 (Table 3A and Suppl. Table 
21 S4A). Genes selected in RadBloodpost-6-based signatures included BAX, FDXR, XPC, DDB2 and 
22 TRIM32 (Table 3B and Suppl. Table S4B). All signatures from this dataset exhibited low 
23 misclassification rates (<0.5% by cross-validation).
Page 21 of 124
E-mail: IJRB@Northwestern.edu  URL: http://mc.manuscriptcentral.com/ijrb






























































1 [Table 3 Here]
2 The radiation gene signatures with the lowest misclassification rates from these datasets 
3 were evaluated against the blood-borne disease confounder datasets that compromised the 
4 accuracies of the M1-M4 and KM3-KM7 signatures (Zhao et al. 2018a). Misclassification rates 
5 were estimated using confounder datasets containing the largest numbers of samples, including 
6 thromboembolism, S. aureus infection, sickle cell disease and malaria. The signature designated 
7 M5 (consisting of AEN and BCL2; Table 3A) showed a significantly elevated FP rate over controls 
8 in blood samples from individuals with thromboembolism (18%) and malaria infection (33%; 
9 Suppl. Table S4A). Misclassification by M5 was increased by 6% in sickle cell disease, which also 
10 exhibited a significantly higher FP rate in an RadBlood-7-derived signature containing AEN (M8; 
11 Table 3A) in sickle cell disease (29%; p<0.05). Removal of genes from M8 significantly increased 
12 the FP rate for both controls and diseased individuals, which is a limitation of models based on 
13 small numbers of genes (Suppl. Table S5A). M9 (Table 3B) includes BAX and FDXR, and 
14 exhibited significantly increased FP rates in thromboembolism relative to controls (34-38% 
15 increased FP). Interestingly, M13 shows a significant increase in FPs of individuals with 
16 thromboembolism (similar to M1-M4), while M11 does not (Table 3B), despite both signatures 
17 containing DDB2. Removing any of the genes from these models did not substantially alter 
18 misclassification, except for a large decrease in FP upon removal of RPS27L from M9 (Suppl. 
19 Table S5B). Both M11 and M13 exhibited significantly high FP rates in malaria samples. BSFS 
20 models derived from dataset RadBloodpost-6 contained FDXR, BAX and DDB2, and showed high 
21 FP in S. aureus, sickle cell disease and malaria samples (significant by statistical analysis; Suppl. 
22 Table S4B). These confounders adversely affect the accuracy of gene signatures containing 
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1 radiation response genes (such as FDXR and AEN) present in both these and other recently derived 
2 signatures in the published literature. 
3 Mitigating expression changes arising from confounding blood disorders with gene signatures 
4 comprising secreted factors originating in blood
5 Highly specific gene expression signatures that identify radiation exposed blood samples should 
6 also minimize inclusion of genes whose expression is altered by other hematological conditions. 
7 Predicted FPs in unexposed patients with confounding conditions may be the result of changes in 
8 expression of DNA damage and apoptotic genes that are shared with radiation responses. We 
9 derived ML-based gene signatures that exclude DNA damage or apoptotic genes which we 
10 anticipated would be less prone to misclassifying individuals with confounding blood disorders. 
11 Changes in transcript levels of extracellular blood plasma proteins resulting from radiation 
12 exposure might exclude those associated with DNA damage or apoptosis response (for example, 
13 FLT3 ligand [FLT3LG] and amylase [AMY; AMY1A, AMY2A]; Barrett et al. 1982; Bertho et al. 
14 2001; Tapio, 2013). This idea is predicated on observations that global protein synthesis 
15 significantly increases 4-8 hr after initial radiation exposures (Braunstein et al. 2009), with some 
16 profile changes detectable weeks to months later (Pernot et al. 2012; Hall et al. 2017). Radiation 
17 signatures in blood have been derived from proteins secreted into plasma (Wang et al. 2020) and 
18 expressed by multiple cell lineages (Ostheim et al. 2021). Radiation-induced short-term changes 
19 in the abundance of mRNAs encoding plasma proteins (that correspond to protein concentration 
20 changes) could allow steady state mRNA expression to be used as a surrogate for plasma protein 
21 levels. Significant correlations between mRNA and protein expression have been shown when the 
22 data have been transformed to normal distributions (Greenbaum et al. 2001; Greenbaum et al. 
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1 2002). This approach was adopted to derive mRNA signatures from radiation responsive genes in 
2 blood encoding secreted factors.
3 Genes which encode secreted proteins were used to derive new radiation gene expression 
4 signatures using our previously described methods (Zhao et al. 2018a). The plasma protein-
5 encoding gene GM2A had the highest MI with radiation in dataset RadTBI-2 (MI=0.31), while 
6 TRIM24 was highest in dataset RadTBI-3 (MI=0.27; Suppl. Table S1). GM2A is absent from 
7 dataset RadTBI-3. MI of TRIM24 was low in RadTBI-2 (MI=0.05) resulting in it being ranked 
8 second to last (Suppl. Table S1) and it was not differentially expressed in this dataset (p-value > 
9 0.05 by t-test; Suppl. Table S6C). Other top 50 ranked genes by mRMR in both datasets include 
10 ACYP1, B4GALT5, FBXW7, IRAK3, MSRB2, NBL1, PRF1, SPOCK2, and TOR1A. 
11 We derived 5 independent radiation gene signatures encoding proteins secreted by blood 
12 cells (e.g. blood secretome models) that showed the lowest cross-validation misclassification 
13 accuracy or log-loss by various feature selection strategies (labeled SM1-SM5 [Secretome Model 
14 1-5] in Table 4 and Suppl. Table S6A). SM5 feature selection was limited to the top 50 genes
15 ranked by mRMR. This pre-selection step was not applied when deriving SM2 and SM3, whereas 
16 SM1 and SM4 were derived by CSFS feature selection which obtains genes sequentially by 
17 mRMR rank order without applying a threshold. Significantly upregulated genes and models 
18 consisted of SLPI (SM1, SM2), TRIM24 (SM3, SM4, SM5), TOR1A (SM3, SM4), GLA (SM4), 
19 SIL1 (SM4), NUBPL (SM4), NME1 (SM4), IPO9 (SM4), IRAK3 (SM5), MTX2 (SM5), and 
20 FBXW7 (SM5). Downregulated genes included CLCF1 (SM1, SM2), USP3 (SM1, SM2), TTC19 
21 (SM2), PFN1 (SM3, SM4, SM5), CDC40 (SM4), SPOCK2 (SM4), CTSC (SM4), GLS (SM4), and 
22 PPP1CA (SM5; Suppl. Table S6C). The models exhibited 12-39% misclassification (by k-fold 
23 validation) when validated against the alternative radiation dataset. The RadTBI-2 dataset was not 
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1 suitable for signature derivation or validation, since data for LCN2, ERP44, FN1, GLS, and 
2 HMCN1 were missing; these genes are present in models SM3 and/or SM4 (Table 4). The 
3 performance of the derived signatures was also assessed by inclusion of FLT3 or AMY, either 
4 individually or in combination. These genes did not improve model accuracy beyond the levels of 
5 the best performing signatures that we derived.
6 [Table 4 Here]
7 The specificity of signatures derived from genes encoding secreted factors was then 
8 evaluated with expression data from unirradiated individuals with blood-borne diseases and 
9 infections (Suppl. Table S6B). SM3 and SM5 correctly classified nearly all samples in each dataset 
10 as unirradiated and maintained a FP rate <5% in all datasets (Figure 6). SM3 and SM5 contain <10 
11 genes, were derived from dataset RadTBI-3 and share the genes TRIM24 and PFN1 (ranked #1 
12 and #21 by mRMR). Both genes are significantly differentially expressed after radiation exposure, 
13 as is TOR1A in SM3 and IRAK3, PPP1CA, MTX2, FBXW7 and CTSC in SM5 (Suppl. Table S6C). 
14 SM3 and SM5 have the highest fraction of genes found significant by Student’s t-test, which may 
15 explain its superior specificity relative to the other blood secretome signatures. Thromboembolism 
16 could only be evaluated with SM3 and SM5 due to missing genes from the SM1, SM2 and SM4 
17 signatures. Conversely, SM1, SM2 and SM4 accuracy was compromised by expression changes 
18 of genes in one or more blood-borne diseases. Malaria (28%) and S. aureus (19%) infected patients 
19 were misclassified by SM1 as FPs (with 0.5% and 6.1% FP in controls, respectively), indicating 
20 that SM1 accuracy was significantly affected by these underlying infections (Suppl. Table S6B). 
21 SM4 accuracy was also impacted by S. aureus infection and sickle cell disease. Since the 
22 predictions of SM3 and SM5 were not influenced by the confounding conditions evaluated here, 
23 we suggest that these models will also be likely to be useful to exclude misclassification by others 
Page 25 of 124
E-mail: IJRB@Northwestern.edu  URL: http://mc.manuscriptcentral.com/ijrb






























































1 confounding conditions. Ultimately, it will be necessary to evaluate these signatures over a wide 
2 spectrum of other potential confounder phenotypes. 
3 [Figure 6 Here]
4 SM3 and SM5 exhibited high specificity for radiation exposure (low false positivity in all 
5 confounding datasets) but were less sensitive than M1-M4 and KM3-KM7 (Table 4). Accurate 
6 identification of radiation exposed individuals should be feasible with a sequential strategy that 
7 first evaluates blood samples with suspected radiation exposures with signatures known to exhibit 
8 high sensitivity (e.g. M4; 88% accuracy to radiation exposure), followed by identification of FPs 
9 among predicted positives with SM3 and/or SM5 (which were not influenced by confounders; 
10 Suppl. Table S6B and S6D). By identifying and removing misclassified, unirradiated samples with 
11 the blood secretome-based radiation signatures, sequential application of both sets of signatures 
12 would predict predominantly TP samples.
13 Discussion
14 We demonstrated high misclassification rates of radiation gene expression signatures in 
15 unirradiated individuals with either infections or blood borne disorders relative to normal controls. 
16 This was confirmed with a second set of k-fold validated radiation signatures from our previous 
17 study (Zhao et al. 2018a). Similar results were obtained with expression data from unirradiated 
18 individuals exhibiting other hematological conditions, which extended the spectrum of other 
19 abnormalities misclassified as exposed to radiation. Some of the same genes that are induced or 
20 repressed by radiation exhibit similar changes in direction and magnitude in infections and 
21 hematological conditions (for example, DDB2, BCL2). Signatures derived from more recent 
22 microarray platforms that contain key radiation response genes missing in our previous study (e.g. 
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1 FDXR, AEN) were also prone to misclassifying hematological confounders as false positives. By 
2 assessing the performance of each model and rejecting signatures with a high rate of false radiation 
3 diagnoses in confounding conditions, many individuals with these comorbidities might be 
4 ineligible for these radiation gene signature assays.
5 The symptoms of prodromal Influenza and ARS significantly overlap. During Influenza 
6 outbreaks, this could impact accurate and timely diagnosis of ARS. Expression-based bioassays 
7 might not improve this diagnostic accuracy, since traditional radiation signatures maximize 
8 sensitivity without accounting for the diminished specificity due to underlying hematological 
9 conditions. Other highly specific tests for radiation exposure, such as the dicentric chromosome 
10 assay, can be more accurate and less variable than expression-based assays, but require more time 
11 in the laboratory despite recent improvements in the speed of these analyses (Rogan et al. 2016; 
12 Liu et al. 2017; Shirley et al. 2017; Li et al. 2019, Shirley et al. 2020). Existing gene expression 
13 assays will need to address the false positive results obtained for individuals with hematological 
14 conditions before they can be used in general populations, who may not have a history of these 
15 conditions or who may have been pre-screened as a precondition to military or space deployment.  
16 Use of matched, unirradiated controls provides a measure of sensitivity and dynamic range 
17 of the derived radiation gene signature. ML models for the same datasets can consist of different 
18 gene sets and are based on different C and sigma values, which can lead to differences in their 
19 ability to predict radiation exposures under different biological conditions. Nevertheless, genes 
20 with high mutual information between radiation amongst confounders consistently show 
21 differences in the distribution of TNs and FPs (Figure 4; Mucaki et al. 2021). That is, the models 
22 tend to unambiguously classify individual samples (Suppl. Fig. 1). Given the shared responses of 
23 different hematopathologies by leukocytes, the specificity of the signature for radiation exposure 
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1 would, under ideal circumstances, be expected to exclude detection of other pathologies. Negative 
2 controls do not exhibit disease symptoms. In a nuclear incident or accident, the exposed population 
3 will include many individuals with underlying comorbidities. Application of radiation signatures 
4 derived by maximizing sensitivity in this population could lead to inappropriate diagnosis, and 
5 possibly treatment for ARS. The sequential gene signature assay design should improve the 
6 specificity of radiation gene expression assays in these individuals, and across the general 
7 population. 
8 The cumulative incidences of these confounders are not rare, especially Influenza which 
9 affected approximately 11% of the US population during the 2019-2020 season (11,575 per 
10 100,000; https://www.cdc.gov/flu/about/burden). The frequency of Dengue fever was also high in 
11 the Caribbean (2,510 per 100,000), Southeast Asia (2,940 per 100,000) and in South Asia (3,546 
12 per 100,000; based on cases from 2017 [Zeng et al. 2017]). The annual prevalence of S. aureus 
13 bacteremia in the US is 38.2 to 45.7 per 100,000 person-years (El Atrouni et al. 2009; Rhee et al. 
14 2015), but is higher among specific populations, such as hemodialysis patients. There are between 
15 350,000 and 600,000 cases (200 per 100,000) of deep vein thromboembolism and pulmonary 
16 embolism that occur in the US every year (Anderson et al. 1991). Furthermore, there are over 
17 100,000 individuals with sickle cell in the US (33.3 per 100,000; Hassell, 2010). Malaria is also 
18 common in sub-Saharan Africa in 2018 (21,910 per 100,000; World Health Organization, 2018). 
19 The prevalence of these diseases makes it clear that they could very well have a severe impact on 
20 assessment in a population-scale radiation exposure event. 
21 Exploring the basis of these confounding disorders could facilitate strategies that minimize 
22 FPs suggesting radiation exposures. Common elements among their molecular etiologies may 
23 provide insight into their high misclassification rates. Despite their different clinical presentations, 
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1 the underlying mechanisms of all of these conditions and radiation exposure appear to culminate 
2 in overwhelming chromosomal damage, degradation and cell lysis. Riboviral infections have been 
3 proposed to sequester host RNA binding proteins, leading to R-loop formation, DNA damage 
4 responses, and apoptosis (Rogan et al. 2021). This study suggested that expression of some key 
5 radiation signature genes appear to be altered by such infections. We also suggest that neutrophil 
6 extracellular traps (or NETs; Qi et al. 2020) may activate biochemical pathways that are present 
7 in early radiation responses. An early step in the formation of these structures is chromosome 
8 decondensation followed by the fragmentation of DNA which act as extracellular fibers which 
9 bind pathogens (such as S. aureus) in a process similar to autophagy in neutrophils (NETosis). 
10 This process would likely activate DNA damage in neutrophils, and some of the same DNA 
11 damage response genes that are activated (DDB2, PCNA, GADD45A) and repressed (BCL2) after 
12 radiation exposure are also similarly regulated after infections such as S. aureus. It has also been 
13 proposed that NET formation affects the severity of malaria infections (Boeltz et al., 2017). 
14 NETosis also contributes to the pathogenesis of numerous non-infectious diseases such as 
15 thromboembolism (Demers and Wagner, 2014; Collison, 2019) and sickle cell disease (Hounkpe 
16 et al. 2020), in addition to autoimmune disease (He et al. 2018) and general inflammation 
17 (Delgado-Rizo et al. 2017). If the origin of the FPs is confined to this lineage, then a comparison 
18 of the predictions of our traditionally validated signatures using data from the granulocyte 
19 versus lymphocyte lineages in individuals with these conditions should reveal whether NETosis is 
20 the likely etiology of the confounder expression phenotypes, or possibly even in radiation treated 
21 cells. To do this for radiation exposed cells, would require RNASeq data from these isolated cell 
22 populations (Ostheim et al. 2021). We would expect FPs in the confounder populations using 
23 signatures derived from myeloid-derived lineages, which include neutrophils.  
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1 The discovery of blood-borne conditions which lead to high FPs raises the question of 
2 whether other hematological conditions could also increase misclassification by radiation gene 
3 signatures. Such datasets are either unavailable or not suitable for analysis. Some studies consist 
4 with too few samples (e.g. GSE69601 [idiopathic portal hypertension] has 6 samples total) or lack 
5 the control samples necessary to perform a proper comparison (e.g. GSE33812 [aplastic anemia]). 
6 Although the available gene expression datasets covered a broad range of hematopathologies, 
7 additional testing of the sequential gene signatures will be required to exclude FPs due to 
8 underlying changes in gene expression from other confounders.
9 Confounding conditions will affect the precision of other assays and biomarkers that are 
10 routinely used to assess radiation exposure. Elevated levels of γ-H2AX, a marker of DNA damage, 
11 occur in cancer (Warters et al. 2005, Banath et al. 2004; Yu et al. 2006, Sedelnikova and Bonner 
12 2006), in ulcerative colitis (Risques et al. 2008) and Zinc depletion/restriction (Mah et al. 2010). 
13 γ-H2AX has been suggested as an early cancer screening and cancer therapy biomarker 
14 (Sedelnikova and Bonner 2006). Besides its application for radiation assessment, the cytokinesis 
15 block micronucleus assay (CBMN; Fenech 2010) is also a multi-target endpoint for genotoxic 
16 stress from exogenous chemical agents (Kirsch-Volders et al. 2011; Fenech et al. 2016, Kirsch-
17 Volders et al. 2018) and deficiency of micronutrients required for DNA synthesis and/or repair 
18 (folate, zinc; Beetstra et al. 2005; Sharif et al. 2012). The specificity of radiation testing may also 
19 be affected in patients with cancer using the γ -H2AX assay and patients under genotoxic stress 
20 and nutrient deficiencies using the CBMN assay. 
21 Many radiation response genes were frequently selected as features for multiple signatures, 
22 and includes genes with roles in DNA damage response (CDKN1A, DDB2, GADD45A, LIG1, 
23 PCNA), apoptosis (AEN, CCNG1, LY9, PPM1D, TNFRSF10B), metabolism (FDXR), cell 
Page 30 of 124
E-mail: IJRB@Northwestern.edu  URL: http://mc.manuscriptcentral.com/ijrb






























































1 proliferation (PTP4A1) and the immune system (LY9 and TRIM22). In general, the removal of 
2 these genes did not significantly alter the FP rate against confounder data. However, the removal 
3 of LIG1, PCNA, PPM1D, PTP4A1, TNFRSF10B, and TRIM22 could partially decrease 
4 misclassification of Influenza samples in some models, as well as DDB2 for Dengue (in addition 
5 to S. aureus and Polycythemia Vera). Many of these genes in our models are also present in other 
6 published radiation gene signatures and assays (Paul and Amundson, 2008; Lu et al. 2014; Oh et 
7 al. 2014; Port et al. 2017; Tichy et al. 2018; Jacobs et al. 2020). Paul and Amundsen (2008) 
8 developed a 74-gene radiation signature comprised of 16 genes present in the human signatures 
9 reported in Zhao et al. (2018a), including CDKN1A, DDB2 and PCNA. Similarly, three of the 5 
10 biomarkers implicated in Tichy et al. (2018) were also commonly selected (CCNG1, CDKN1A, 
11 and GADD45A), as were 5 of the 13 genes in the radiation assay described in Jacobs et al. (BAX, 
12 CDKN1A, DDB2, MYC and PCNA). While we cannot determine the impact on the accuracy of 
13 their signatures for confounders, it is evident that some genes that are included in these and other 
14 gene signatures (such as DDB2) can have a profound impact on the misclassification of individuals 
15 with confounding conditions. 
16 [Figure 7 Here]
17 The proposed sequential approach that combines highly sensitive predictors (affected by 
18 confounders) with high-specificity signatures could improve the accuracy of predicting TP 
19 exposures (Figure 7). After assessment with a sensitive signature (e.g. M4), all predicted positive 
20 samples would be re-evaluated with a high specificity signature (e.g. SM3 or SM5) to remove 
21 misclassified FP samples resulting in a higher performance assay that predominantly or 
22 exclusively labels truly irradiated samples. Datasets derived from different post-exposure times 
23 and exposures (RadLymphCL-1, RadTBI-2, RadTBI-3, RadBloodpost-6, and RadBlood-7) could 
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1 generate ML models which can be used to assess the extent to which hematological confounders 
2 influence radiation exposure predictions for a variety of exposures and post-irradiation time 
3 constraints. A signature can be derived and selected which best fits the circumstances of the 
4 radiation exposure profile of a potentially exposed individual. The high specificity signatures, SM3 
5 and SM5, were not as sensitive to misclassification as M1-M4 and KM1-KM7. It is conceivable 
6 that a proportion of radiation-exposed individuals could be misclassified as FNs if samples were 
7 evaluated solely with these signatures. Besides radiation exposure, the application of sequential 
8 gene signatures, each optimized respectively to maximize sensitivity and specificity, may turn out 
9 to be a general strategy for improving accuracy of molecular diagnoses for a wide spectrum of 
10 disease pathologies.
11 Differential molecular diagnoses based on gene signatures would evaluate predicted 
12 radiation positive samples by individual gene signatures, each trained on different confounders 
13 (e.g. one model for Influenza infection, another for thromboembolism, etc). This approach would 
14 explicitly exclude FPs for radiation response while identifying the underlying condition. Separate 
15 signatures for sensitivity and specificity might also be avoided by training adversarial networks 
16 (Goodfellow et al. 2014) that contrast radiation-exposed samples with one or more datasets for 
17 confounding conditions, with emphasis on samples predicted to be FPs from the current radiation 
18 signatures. These resultant signatures would select radiation responsive genes which are resistant 
19 to the effects of confounders. Finally, ensuring that both the positive test and negative control 
20 samples in training sets properly account for the population frequencies of confounding diagnoses 
21 would also be expected to improve the performance of radiation gene signatures.
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2 Figure 1: Evaluation of Conditions Confounding Radiation Gene Signatures
3 The traditional validation approach was used to evaluate unirradiated datasets for hematological 
4 conditions to assess the performance of radiation gene signatures derived in Zhao et al. (2018a). 
5 With this approach, we can identify and then reject models with high rates of FP radiation 
6 diagnosis in confounding conditions while identifying what confounders could make individuals 
7 ineligible for a radiation gene signature assay. Alternatively, new radiation gene signatures could 
8 be derived that show improved FP rates in both controls and test subjects.
9
10 Figure 2: Performance of Traditionally-Validated Radiation Signatures on Confounders 
11 Stratified by Sub-phenotypes  
12 Sankey diagrams delineate what fraction of disease patients and controls were properly (TN) and 
13 improperly classified (FP) by a radiation gene signature. A) The radiation signature M4 incorrectly 
14 classified 53% of Dengue-infected patient as irradiated, however all convalescent patients were 
15 properly classified (0% FP). B) Similarly, the FP rate of M1 decreased considerably after patient 
16 recovery (27% FP rate [N=19] against samples <3 days after symptoms; 3% [N=2] after 2-5 
17 weeks). C) The FP rate of M3 was higher for severe malarial anemia patients versus those with 
18 cerebral malaria, suggesting that the differential expression caused by the two infection types may 
19 diverge in such a way that is measurable by M3. D) Conversely, the FP rate of venous 
20 thromboembolism patients by M4 was not influenced on whether the disease was recurrent. 
21
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1 Figure 3: Misclassification Rates of Radiation Models in Unirradiated Blood-borne 
2 Disorders
3 Radiation gene signatures M1-M4 and KM3-KM7 performed well when predicting radiation 
4 exposure (≥80% overall accuracy; Table 2). However, many of these models falsely predicted 
5 individuals with blood-borne disorders (thromboembolism [A] and sickle cell disease [C]) and 
6 infectious diseases (S. aureus [B] and malaria [D]) as irradiated (%FP provided for individuals 
7 with the indicated disease [dark grey; top value], and controls [light grey; bottom value]). Asterisks 
8 indicate when the differences between the FP counts in controls and diseased individuals were 
9 significant with both Mantel-Haenszel chi square and mid-P exact tests (one-tailed; p<0.05). In 
10 general, the FP rate was high for all traditional validated (M1-M4) and most k-fold validated 
11 models (KM4, KM6 and KM7). Models KM3 and KM5 had a low FP rate across all datasets 
12 tested.
13
14 Figure 4: DDB2 and BCL2 Expression in Hematological Disorders with Radiation-Exposed 
15 Control Datasets
16 Normalized distribution of gene expression of confounder datasets (VTE: Venous 
17 Thromboembolism [orange]; SAu: S. aureus [teal]; Sic: Sickle Cell [yellow]; and Mal: Malaria 
18 [dark green]) for the genes A) DDB2 and B) BCL2 are presented as violin plots, where the 
19 expression of individuals with these conditions are divided by those predicted as irradiated (FP; 
20 left) or unirradiated (TN; right) by signature M4. Control expression of radiation-exposed (Irr.) 
21 and (Non.) unirradiated individuals are indicated by distributions labeled with light (dataset 
22 RadTBI-2) and dark (dataset RadTBI-3) red outlines on the right side of each panel. All expression 
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1 differences between FP and TN samples (predicted with signature M4) found to be significant by 
2 Student’s t-test (assuming two-tailed distribution and equal variance) are indicated by brackets 
3 above the corresponding pair of predictions.
4
5 Figure 5: Multiple Genes Contribute to Misclassification of Confounding Datasets
6 Accuracy of M4 (Zhao et al. 2018a [Table 3B]) was significantly influenced by hematological 
7 confounders such as venous thromboembolism (top) and S. aureus infection (bottom). M4 
8 misclassified diseased individuals (orange circles) far more often than controls (blue squares). 
9 Feature removal analysis of M4 determines if a particular gene was contributing to the %FP rate 
10 by observing how accuracy changes when a gene is removed. While M4 accuracy improved with 
11 the removal of PRKDC, IL2RB and LCN2, no individual gene restored misclassification back to 
12 control levels suggesting multiple genes are confounded by these diseases. 
13
14 Figure 6: Radiation Gene Signatures derived from Transcripts Encoding Secreted Factors 
15 Reduce Misclassification in Unirradiated Confounder Phenotypes
16 Radiation signatures which consist exclusively of genes encoding for plasma secreted proteins 
17 were derived following the same basic approach of Zhao et al. (2018a). These models showed 
18 generally favorable performance when tested against an independent radiation dataset by k-fold 
19 validation (Table 4). Five blood secretome radiation signatures were derived consisting of 7-75 
20 genes (SM1-SM5). Two models (SM3 and SM5) show high specificity across all hematological 
21 conditions tested (thromboembolism [A], S. aureus [B], sickle cell disease [C]) and malaria [D]).
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3 Figure 7: Sequential Application of Radiation-responsive and Blood Secretome Gene 
4 Signatures Identifies Exposed Individuals
5 False positive predictions due to differential expression caused by confounding conditions could 
6 be mitigated by following a sequential approach where samples are evaluated with both a highly 
7 sensitive radiation gene signature and a second signature with high specificity. M4, for example, 
8 is highly sensitive when validated against radiation dataset RadTBI-3 (88% accuracy), where all 
9 incorrect classifications were due to FP predictions (zero false negatives [FN]). Predicted 
10 irradiated samples could then be evaluated with a highly specific model such as SM3, which would 
11 identify and remove any misclassified unirradiated samples remaining in the set and leave only 
12 TPs.
13
14 Supplemental Figure 1: Threshold Mapping of Venous Thromboembolism Patients 
15 Predicted Irradiated by Model M4
16 The expression of DDB2, PCNA, IL2RB and PRKDC from all thrombosis patients (BBD-Thromb) 
17 (blue) and controls (orange) are presented as a histogram (non-normalized expression in 0.1 bins). 
18 The expression for patients GSM474822 (A), GSM474828 (B) and GSM474819 (C), each of 
19 which having been improperly classified as irradiated by M4, are indicated with a blue arrow. We 
20 iterated on patient gene expression for each gene and determined at which point the prediction 
21 switched from one class to the other (irradiated/unirradiated). The vertical dashed blue line 
22 designates the inflection point where expression of the gene will alter the prediction of the model. 
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1 If the inflection point is absent, no change in gene expression could correct patient 
2 misclassification, which may indicate that the gene does not strongly contribute to the FP 
3 prediction of that individual. 
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samples d Array Platform Reference(s)
Radiation-exposed:
[RadLymphCL-1] 
GSE1725a 57/57 5 (4 hr) Lymph. CL Af. U95 V2 Rieger … 2004
[RadTBI-2] GSE6874 
[GPL4782]a,e 27/51 2 (6 hr) TBI Operon V3.0.2 Dressman … 2007
[RadTBI-3] GSE10640 




12,24 hr) Lymph. CL Af. U95A Jen and Cheung 2003
[RadLymphCL-5] 
GSE26835a 362/362
f 10 (2,6 hr) Lymph. CL Af. HG-U133A 2.0 Smirnov ... 2012
[RadBloodpost-6] 




Af. HT HG-U133+ van Oorschot…2017
[RadBlood-7] GSE102971a 80/20 2,5,6,7 (24 hr) Blood-Healthy Ag. 4x44K v2 Park … 2017
[RadBloodpost-8] E-




Af. HG-U133A Svensson ... 2006






Phenotype of samples d Array Platform Reference(s)
[BBD-Malaria] GSE117613 a 34/12 Malaria Il. HT-12 V4.0 Nallandhighal…2019
[BBD-Sickle] GSE35007 a 250/61 Sickle Cell Il. HT-12 V4.0 Quinlan ... 2014
[BBD-Polycyt] GSE47018 a 20/7 Polycythemia vera Af. HG-U133A Spivak ... 2014
[BBD-Thromb] GSE19151 a 70/63 Thrombosis Af. HG-U133A 2.0 Lewis ... 2011
[BBD-Saureus] GSE30119 a 99/44 S. aureus Il. HT-12 V3.0 Banchereau ... 2012
[BBD-Aanemia] GSE16334 a 21/11 Aplastic anemia Af. HG-U133A Vanderwerf ... 2009
[BBD-Flu85] GSE29385 a 71/84 Influenza Il. HT-12 V4.0 NA
[BBD-Flu50] GSE82050 a 24/15 Influenza Ag. SurePrint G3 GE v3 Tang ... 2017
[BBD-Flu28] GSE50628 a 10/10 Influenza Af. HG U133+ 2.0 Tsuge ... 2014
[BBD-Flu21] GSE61821 a 238/164 Influenza Il. HT-12 v4.0 Hoang ... 2014
[BBD-Flu31] GSE27131 a 7/14 Influenza Af. HG 1.0 ST Berdal ... 2011
[BBD-Deng61] GSE97861 a 27/3 Dengue fever RNASeq Tian ... 2017
[BBD-Deng62] GSE97862 a 20/24 Dengue fever RNASeq Tian ... 2017
[BBD-Deng08] GSE51808 a 28/9 Dengue fever Af. HT HG-U133+ Kwissa ... 2014
[BBD-Deng78] GSE58278 a 12/6 Dengue fever Il. HT-12 v4.0 Olagnier ... 2014
a Gene Expression Omnibus; b Array Express; c All radiated samples were exposed ex vivo (except datasets 
RadTBI-2 and RadTBI-3, which were patients undergoing total body irradiation [TBI]). Other controls were 
obtained from healthy individuals; d All exposed and unirradiated control samples were from blood, except from 
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datasets RadLymphCL-1, RadLymphCL-4 and RadLymphCL-5, which were lymphoblastoid cell line cultures 
irradiated in vitro; e Study utilized multiple array platforms; f Samples taken 2- and 6-hours post-radiation 
(N=362 each) were evaluated independently. g All confounder datasets are sourced from blood except for BBD-
Aanemia (bone marrow cells), BBD-Deng61 (T cells) and BBD-Deng78 (in vitro infected monocyte-derived 
dendritic cells). BBD – Blood Borne Disease; NA - Not Available; CL - Cell Line; Lymph. - Lymphoblastoid 
cell lines; pts - patients; RT - Radiation Therapy; Af. - Affymetrix; Ag. - Agilent; Il – Illumina; RNASeq – 
Normalized expression from RNA sequencing.
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Table 2 – Traditional and K-Fold Validated Radiation Gene Expression Signatures M1-M4 and KM1-KM7
Signature FS. Algorithm Accuracy1
a) Derived from Radiation Dataset RadLymphCL-1 (GSE1725)
KM1 GADD45A DDB2 FSFS 93%
KM2
PPM1D DDB2 CCNF CDKN1A PCNA GADD45A PRKAB1 TOB1 TNFRSF10B MYC CCNB2 PTP4A1 BAX 
CCNA2 ATF3 LIG1 CCNG1 FHL2 PPP1R2 MBD4 RASGRP2 UBC NINJ1 TRIM22 IL2RB TP53BP1 
PTPRCAP EEF1D PTPRE RAD23B EIF2B4 STX11 PTPN6 STK10 PSMD1 BTG3 MLH1 RNPEP HSPD1 
UNG PTPRC PTPRA BCL2 GSS SH3BP5 TPP2 IDH3B CCNH STK11 EIF4EBP2 HSPA4 FADS2 RPA3 
GZMK ANXA4 ICAM1 PPID LMO2 PPIE NUDT1 FUS POLR2A LY9 RPA1 PTS TNFRSF4 RPA2 PSMD8 
GCDH MAN2C1 PTPN2 RUVBL1 ATP5H GK CD79B MAP4K4 POLE3 PRKCH AKT2 MOAP1 CCNG2 
ALDOA SRD5A1 HAT1 XRCC1 EIF2S3 RAD1 UBE2A ZFP36L1 CD8A TALDO1 GPX4 SSBP2 ERCC3 
ATP5O PEPD EIF4G2 ACO2 HEXB UBE3A ARPC1A PSMD10 PRCP PPIB ZNF337 CETN2 RPL29
CSFS 93%
b) Derived from Radiation Dataset RadTBI-3 (GSE10640[GPL6522])
M1 DDB2 HSPD1 MAP4K4 GTF3A PCNA MDH2 FSFS 86%
M2 DDB2 GTF3A TNFRSF10B FSFS 80%
KM3
DDB2 RAD17 PSMD9 LY9 PPIH PCNA MDH2 MOAP1 TP53BP1 PPM1D ATP5G1 BCL2L2 ENO2 
PTP4A1 PSMD8 LIG1 FDPS OGDH CCNG1 PSMD1 BSFS 95%
KM4 DDB2 HSPD1 ICAM1 PTP4A1 GTF3A LY9 FSFS 92%
KM5
RAD17 TNFRSF10B PSMD9 LY9 PPIH PCNA ZNF337 MDH2 TP53BP1 PPM1D ZFP36L1 ATP5G1 
ALDOA BCL2L2 ENO2 GADD45A PTP4A1 PSMD8 LIG1 ATP5O FDPS OGDH PSMD1 BSFS 95%
c) Derived from Radiation Dataset RadTBI-2 (GSE6874[GPL4782])
M3 DDB2 CD8A TALDO1 PCNA EIF4G2 LCN2 CDKN1A PRKCH ENO1 PPM1D BSFS 88%
M4
DDB2 CD8A TALDO1 PCNA LCN2 CDKN1A PRKCH ENO1 GTF3A IL2RB NINJ1 BAX TRIM22 PRKDC 
GADD45A MOAP1 ARPC1B LY9 LMO2 STX11 TPP2 CCNG1 GABARAP BCL2 GSS FTH1 BSFS 92%
KM6 DDB2 PRKDC PRKCH IGJ FSFS 98%
KM7 DDB2 PRKDC TPP2 PTPRE GADD45A FSFS 98%
 1 Performance metrics for these radiation gene signatures were previously reported in Zhao et al. (2018a) Tables 2 (k-fold validated signatures 
[KM1-KM7]) and 3 (traditionally validated signatures [M1-M4]); FS – Feature Selection metrics
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Table 3 – Radiation Gene Expression Signatures derived from RadBloodpost-6 and RadBlood-7 Radiation Datasets





Loss Thrombosis S. Aureus Sickle Cell Malaria
a) Derived from Radiation Dataset RadBlood-7 (GSE102971)
M5 AEN BCL2 FSFS 1 - 8.1E-15 0.57 / 0.40 2 0.48 / 0.41 0.49 / 0.43 0.41 / 0.08 2
M6 RPS27L ZMAT3 FSFS - 5.2E-15 0.78 / 0.69 0.49 / 0.46 0.50/ 0.43 0.71 / 0.25 2
M7 AEN ERCC1 BAX CSFS 0% - 0.60 / 0.83 2 0.71 / 0.66 0.66 / 0.72 0.68 / 0.42
M8 AEN TNFRSF10B FSFS - 5.2E-15 0.00 / 0.00 0.00 / 0.00 0.56 / 0.26 2 1.00 / 1.00
b) Derived from Radiation Dataset RadBloodpost-6 (GSE85570)
M9 BAX FDXR FSFS 0% - 0.64 / 0.27 2 0.46 / 0.64 2 0.52 / 0.33 2 0.44 / 0.75 2
M10 BAX FDXR XPC FSFS 0% - 0.80 / 0.46 2 0.84 / 0.65 2 0.67 / 0.69 0.68 / 1.00 2
M11 BAX DDB2 FSFS 0% - 0.34 / 0.76 2 0.52 / 0.48 0.48 / 0.49 0.59 / 0.17 2
M12 BAX DDB2 SLC7A6 FSFS 0% - 0.51 / 0.31 2 0.40 / 0.23 2 0.41 / 0.47 0.44 / 0.20
M13 RPS27L DDB2 ARL6IP1 TRIM32 FSFS 0% - 0.77 / 0.40 2 0.63 / 0.55 0.54 / 0.67 2 0.68 / 0.25 2
1 Gene Signatures derived using 0Gy, 2Gy and 5Gy samples only (excludes 6Gy and 7Gy samples from RadBlood-7); 2 
Difference in FPs between controls and test subjects significant by Mantel-Haenszel chi square and mid-P exact tests (p≤0.05); 
Additional Models can be found in Suppl. Tables S4A and S4B; FS – Feature Selection metrics (by leave-one-out cross-
validation)
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a) Derived from Radiation Dataset RadTBI-2 (GSE6874[GPL4782]) and Validated on RadTBI-3
(GSE10640[GPL6522])
SM1
PDE7A FBXW7 CLCF1 ALB IDUA USP3 SLPI COASY MFAP4 LTBP1 VPS37B 
VEGFA IRAK3 CSFS 0.12 0.25
SM2
PDE7A FBXW7 CLCF1 ALB IDUA USP3 SLPI COASY MFAP4 LTBP1 VPS37B 
VEGFA IRAK3 MZB1 DHH GRN AEBP1 CNPY3 NUCB1 RDH11 CXCL3 
POFUT1 CST1 ARCN1 PLA2G12A ERAP2 GOLM1 B3GAT3 ADAMTS9 FKBP9 
ALDH9A1 LY86 HARS2 PRSS21 RETN C1GALT1 MGAT2 FUCA1 TTC19 MANF 
LUM GALNT15 APOM NME1 ATMIN GPX4 POLL LY6H SMARCA2
BSFS 0.12 0.27
b) Derived from Radiation Dataset RadTBI-3 (GSE10640[GPL6522]) and Validated on RadTBI-2
(GSE6874[GPL4782])
SM3 TRIM24 TOR1A GRN HP RBP4 PFN1 FN1 FSFS 0.32 0.49
SM4
XCL1 CDC40 PTGS2 DHX8 NENF PTX3 WNT1 CTSW TINF2 AOAH VPS51 
TOR1A HINT2 CRTAP SUCLG1 TF EDEM2 LAMA5 AGPS TFPI WFDC2 SRGN 
SIL1 PPOX AMY2A NUBPL GARS LRPAP1 VPS37B PNP C3orf58 HP SPOCK2 
NME1 GRN TRIM24 MRPL34 SRP14 THOC3 RNASE6 RBP4 MSRB2 RNASET2 
TGFBI PRDX4 GLA GLB1 PFN1 GDF15 VCAN TRIM28 TAGLN2 TIMP1 IPO9 
CPVL MANBA CEP57 RNF146 PF4 RETN HCCS DPP7 RNASE2 QPCT AHSG 
CTSC LYZ B2M EMILIN2 STOML2 LCN2
CSFS 0.39 0.32
SM5 TRIM24 IRAK3 PPP1CA MTX2 FBXW7 PFN1 SDHB CTSC MSRB2 FSFS2 0.33 0.38
Additional Metrics for these signatures can be found in Suppl. Table S6A; 1 Tested using K-Fold validation methods (where K=5)
2 Derived from the top 50 genes by ranked mRMR (Suppl. Table S1); FS – Feature Selection metrics
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Figure 1. Evaluation of Conditions Confounding Radiation Gene Signatures. The traditional validation 
approach was used to evaluate unirradiated datasets for hematological conditions to assess the performance 
of radiation gene signatures derived in Zhao et al. (2018a). With this approach, we can identify and then 
reject models with high rates of FP radiation diagnosis in confounding conditions while identifying what 
confounders could make individuals ineligible for a radiation gene signature assay. Alternatively, new 
radiation gene signatures could be derived that show improved FP rates in both controls and test subjects. 
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Figure 2. Performance of Traditionally-Validated Radiation Signatures on Confounders Stratified by Sub-
phenotypes.  Sankey diagrams delineate what fraction of disease patients and controls were properly (TN) 
and improperly classified (FP) by a radiation gene signature. A) The radiation signature M4 incorrectly 
classified 53% of Dengue-infected patient as irradiated, however all convalescent patients were properly 
classified (0% FP). B) Similarly, the FP rate of M1 decreased considerably after patient recovery (27% FP 
rate [N=19] against samples <3 days after symptoms; 3% [N=2] after 2-5 weeks). C) The FP rate of M3 
was higher for severe malarial anemia patients versus those with cerebral malaria, suggesting that the 
differential expression caused by the two infection types may diverge in such a way that is measurable by 
M3. D) Conversely, the FP rate of venous thromboembolism patients by M4 was not influenced on whether 
the disease was recurrent. 
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Figure 3. Misclassification Rates of Radiation Models in Unirradiated Blood-borne Disorders. Radiation gene 
signatures M1-M4 and KM3-KM7 performed well when predicting radiation exposure (≥80% overall 
accuracy; Table 2). However, many of these models falsely predicted individuals with blood-borne disorders 
(thromboembolism [A] and sickle cell disease [C]) and infectious diseases (S. aureus [B] and malaria [D]) 
as irradiated (%FP provided for individuals with the indicated disease [dark grey; top value], and controls 
[light grey; bottom value]). Asterisks indicate when the differences between the FP counts in controls and 
diseased individuals were significant with both Mantel-Haenszel chi square and mid-P exact tests (one-
tailed; p<0.05). In general, the FP rate was high for all traditional validated (M1-M4) and most k-fold 
validated models (KM4, KM6 and KM7). Models KM3 and KM5 had a low FP rate across all datasets tested. 
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Figure 4. DDB2 and BCL2 Expression in Hematological Disorders with Radiation-Exposed Control Datasets. 
Normalized distribution of gene expression of confounder datasets (VTE: Venous Thromboembolism 
[orange]; SAu: S. aureus [teal]; Sic: Sickle Cell [yellow]; and Mal: Malaria [dark green]) for the genes A) 
DDB2 and B) BCL2 are presented as violin plots, where the expression of individuals with these conditions 
are divided by those predicted as irradiated (FP; left) or unirradiated (TN; right) by signature M4. Control 
expression of radiation-exposed (Irr.) and (Non.) unirradiated individuals are indicated by distributions 
labeled with light (dataset RadTBI-2) and dark (dataset RadTBI-3) red outlines on the right side of each 
panel. All expression differences between FP and TN samples (predicted with signature M4) found to be 
significant by Student’s t-test (assuming two-tailed distribution and equal variance) are indicated by 
brackets above the corresponding pair of predictions. 
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Figure 5. Multiple Genes Contribute to Misclassification of Confounding Datasets. Accuracy of M4 (Zhao et al. 
2018a [Table 3B]) was significantly influenced by hematological confounders such as venous 
thromboembolism (top) and S. aureus infection (bottom). M4 misclassified diseased individuals (orange 
circles) far more often than controls (blue squares). Feature removal analysis of M4 determines if a 
particular gene was contributing to the %FP rate by observing how accuracy changes when a gene is 
removed. While M4 accuracy improved with the removal of PRKDC, IL2RB and LCN2, no individual gene 
restored misclassification back to control levels suggesting multiple genes are confounded by these diseases. 
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Figure 6. Radiation Gene Signatures derived from Transcripts Encoding Secreted Factors Reduce 
Misclassification in Unirradiated Confounder Phenotypes
Radiation signatures which consist exclusively of genes encoding for plasma secreted proteins were derived 
following the same basic approach of Zhao et al. (2018a). These models showed generally favorable 
performance when tested against an independent radiation dataset by k-fold validation (Table 4). Five blood 
secretome radiation signatures were derived consisting of 7-75 genes (SM1-SM5). Two models (SM3 and 
SM5) show high specificity across all hematological conditions tested (thromboembolism [A], S. aureus [B], 
sickle cell disease [C]) and malaria [D]). 
Page 64 of 124
E-mail: IJRB@Northwestern.edu  URL: http://mc.manuscriptcentral.com/ijrb





























































Figure 7. Sequential Application of Radiation-responsive and Blood Secretome Gene Signatures Identifies 
Exposed Individuals
False positive predictions due to differential expression caused by confounding conditions could be mitigated 
by following a sequential approach where samples are evaluated with both a highly sensitive radiation gene 
signature and a second signature with high specificity. M4, for example, is highly sensitive when validated 
against radiation dataset RadTBI-3 (88% accuracy), where all incorrect classifications were due to FP 
predictions (zero false negatives [FN]). Predicted irradiated samples could then be evaluated with a highly 
specific model such as SM3, which would identify and remove any misclassified unirradiated samples 
remaining in the set and leave only TPs. 
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